Biosimilar Use in Cancer Treatment

Biosimilars are already in use in other therapeutic areas in Canada, but are only now becoming available in oncology MD Analytics explored the attitudes and perceptions of 31 Oncologists and Hematologists regarding biosimilars.The majority of Oncologists and Hematologists have some knowledge of biosimilars, but there is room to improve familiarity:
Read more...

;